Ad
BEAT - Heartbeam Stock Trading
About | Heartbeam Inc. (NASDAQ:BEAT)
Not available
Quote | Heartbeam Inc. (NASDAQ:BEAT)
| Last: | $1.47 |
|---|---|
| Change Percent: | -2.04% |
| Open: | $1.5 |
| Close: | $1.47 |
| High: | $1.5 |
| Low: | $1.4278 |
| Volume: | 26,408 |
| Last Trade Date Time: | 12/04/2023 03:00:00 am |
News | Heartbeam Inc. (NASDAQ:BEAT)
-
HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, allowing for the creation of rich data for artificial intelligence (“AI”), is reporting...
-
2023-11-14 19:10:26 ET HeartBeam, Inc. (BEAT) Q3 2023 Earnings Conference Call November 14, 2023 04:30 PM ET Company Participants Branislav Vajdic - Chief Executive Officer & Founder Rob Eno - President Rick Brounstein - Chief Financial Officer Conferen...
Message Board Posts | Heartbeam Inc. (NASDAQ:BEAT)
| Subject | By | Source | When |
|---|---|---|---|
| It's dead | starkd748 | investorshub | 05/10/2023 7:45:27 PM |
| $BEAT green to start the afternoon 2.22 up! | budfoxfun | investorshub | 05/09/2023 4:06:34 PM |
| $BEAT Funding to Enable Company to Execute on | jedijazz | investorshub | 05/08/2023 3:13:08 PM |
| Time for this to show some returns | TopPick | investorshub | 05/07/2023 4:36:32 AM |
| Price gaining last up | jedijazz | investorshub | 05/04/2023 5:40:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, allowing for the creation of rich data for artificial intelligence (“AI”), is reporting...
-
Strengthens Leadership with Appointments to Executive Team and Boards Publishes Landmark Peer-Reviewed Article, Validating Technology Ongoing Clinical and Regulatory Progress for the HeartBeam AIMIGo ™ VECG Device Management to Host Webcast and Conference Call T...
-
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...